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MaBACKGROUND Obstructive sleep apnea (OSA) importantly contributes to the occurrence of atrial ﬁbrillation (AF)
in humans, but the mechanisms are poorly understood. Experimental research has provided insights into AF promotion
by acute OSA episodes. However, patients with OSA usually have frequent nocturnal episodes for some time before
manifesting AF.
OBJECTIVES The goal of this study was to test the hypothesis that repetitive OSA causes cardiac remodeling that
predisposes to AF.
METHODS We mimicked OSA by using a mechanical ventilator and closing the airway at end-expiration with a 3-way
stopcock (OSA rats). Matched control groups included rats with the ventilator stopped but airway left open (open airway
rats) and continuously ventilated rats (sham rats). OSA rats were exposed to 20 consecutive 2-min cycles of 40 s of
apnea/80 s of ventilation per day, 5 days per week for 4 weeks.
RESULTS OSA signiﬁcantly increased the duration of AF from (median [interquartile range]) 2.6 s [1.9 s to 8.9 s]
(shams) and 16 s [1.8 s to 93 s] (open airway) to 49s [34 s to 444 s]. AF inducibility increased to 56% (9 of 16) of OSA
rats; this is up from 15% (2 of 13) and 13% (2 of 15) in open airway and sham rats, respectively (p < 0.05). OSA rats
exhibited substantial atrial conduction slowing on optical mapping, along with connexin-43 down-regulation on both
quantitative immunoﬂuorescence (expression reduced by 58% vs sham rats) and Western blot (reduced by 38%), as well
as increased atrial ﬁbrous tissue content (by 71%). OSA also caused left ventricular hypertrophy, dilation, and diastolic
dysfunction and enhanced AF inducibility during superimposed acute OSA episodes to 82.4% of rats.
CONCLUSIONS Chronically repeated OSA episodes cause AF-promoting cardiac remodeling, with conduction abnor-
malities related to connexin dysregulation and ﬁbrosis playing a prominent role. This novel animal model provides
mechanistic insights into an important clinical problem and may be useful for further exploration of underlying mech-
anisms and therapeutic approaches. (J Am Coll Cardiol 2014;64:2013–23) © 2014 by the American College of Cardiology
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2014sympathovagal imbalance (6), and structural
remodeling (7,8). We recently reported that
negative intrathoracic pressure changes dur-
ing acute obstructive apnea promote AF, pri-
marily by causing acute left atrial (LA)
dilation (9).SEE PAGE 2024Most patients with OSA experience re-
peated nocturnal OSA episodes. It is conceiv-
able that such repeated events lead to cardiac
remodeling. Indeed, patients with repetitive
OSA exhibit LA dilation and left ventricular
(LV) hypertrophy associated with AF occur-
rence (10,11). However, the long-term cardiac
effects of repetitive OSA on atrial propertiesand AF susceptibility have not been studied in exper-
imental models. The present study was designed to
assess the long-term effects of repetitive OSA on
cardiac structure/function and AF susceptibility in a
rat model.
METHODS
Only the principal methods are provided here; the
Online Appendix provides a detailed description of
the methods.Recovery
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same cycles but with open (instead of closed) airways
as ventilated throughout the procedure. FiO2 ¼ fractionLONG-TERM OSA-MODEL. Twelve-week-old male
Sprague-Dawley rats were intubated and ventilated
with 2% isoﬂurane/room air. Volume-controlled
ventilation was delivered with a tidal volume and
respiratory rate of 2.5 ml and 72 cycles/min, respec-
tively. OSA was mimicked by closing the airway at end
expiration for 40 s, followed by 80-s recovery periods,
20 consecutive times per day (Figure 1). After OSA
cycles, rats were ventilated with room air during
recovery from anesthesia and then extubated after
conﬁrming spontaneous respiration. No complications
resulted from anesthesia, ventilation, or OSA. OSA
cycles were repeated daily (5 days per week for 4
weeks). Two control groups were studied: 1) open
airway rats subjected to the same ventilator-arrest
cycles but without airway closure; and 2) sham rats
ventilated with isoﬂurane/room air throughout the
procedure. Animals in all 3 groups were subjected to
daily oropharyngeal intubation for ventilation. No
animal showed signs of complications of intubation
such as stridor or tachypnea. After 4 weeks, in vivo
electrophysiological studies and AF induction assess-
ments were performed, and tissues were procured.
A 3-F pressure-transducer catheter (Scisense
P-catheter; Scisense Inc., London, Ontario, Canada)
was introduced into the esophagus close to the LA
posterior wall to monitor intrathoracic pressure in 6
OSA rats and 5 open airway rats. For blood pressure
monitoring, a 2-F pressure transducer catheter (Sci-
sense P catheter-RAT) was introduced into the
ascending aorta through the left internal carotid
artery.
IN VIVO ELECTROPHYSIOLOGICAL STUDY. To mea-
sure effective refractory periods (ERPs), programmed
right atrial (RA) stimulation was performed at a cycle
length of 150 ms (pulse width 2 ms, 2  threshold
current). Atrial and atrioventricular (AV) conducting
system ERPs were deﬁned as the longest S1–S2
coupling interval failing to generate a propagated
beat. To assess atrial tachyarrhythmia inducibility,
25-Hz burst pacing (pulse width 2 ms, 4  threshold
current) was applied for 3 s, with 6 3-s burst cycles
separated by 1-s intervals. AF was deﬁned as a rapid
(>800 beats/min) irregular atrial rhythm, and AF
inducibility was deﬁned as AF lasting for at least 1 s
immediately after the 6-burst cycle protocol. If AF
was induced after <6 burst pacing cycles, burst pac-
ing was suspended to avoid interfering with the
evolution of the AF. AF duration was determined in
each rat as the mean duration of all AF episodes. If
burst pacing at baseline did not induce AF, the same
pacing protocol was repeated during acute OSA.
Wenckebach cycle length was deﬁned by failure of
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FIGURE 2 Effect of Acute OSA on LA Diameter
Comparisons by 2-way repeated measures analysis of variance/
Bonferroni-adjusted Student t tests. *p<0.05, ***p<0.001 vs.
Open. LA ¼ left atrial; OSA ¼ obstructive sleep apnea.
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20151:1 AV conduction, determined by RA pacing with
decremental 5-ms steps. Sinus node recovery time
was determined by 30-s RA pacing with a 150-ms
cycle length.
ECHOCARDIOGRAPHY. Transthoracic echocardio-
graphic studies were performed at baseline and after
the 4-week preparation interval with a phased array
10S probe (4.5 to 11.5 MHz) in a Vivid 7 Dimension
system (GE Healthcare Ultrasound, Horten, Norway),
under sedation with 2% isoﬂurane. The Online
Appendix presents details regarding the echocardio-
graphic methods.
PROTEIN EXTRACTION AND WESTERN BLOT.
Freshly isolated LA samples were snap-frozen in
liquid nitrogen and mechanically homogenized in
TNE (Tris-NaCl-EDT) buffer containing the following:
Tris 25 mmol/l, EDT (ethylenediaminetetraacetic)
acid 5 mmol/L, EGTA (ethylene glycol-bis[2-amino-
ethylether]-N,N,N0,N0-tetraacetic acid) 5 mmol/l, NaCl
150 mmol/l, NaF 20 mmol/l, Na3VO4 0.2 mmol/l,
a-glycerophosphate 20 mmol/l, AEBSF (4-[2-Amino-
ethyl]benzenesulfonyl ﬂuoride hydrochloride) 0.1
mmol/l, leupeptin 25 mg/ml, aprotinin 10 mg/ml,
pepstatin 1 mg/ml, microcystin-LR 1 mmol/l, pH 7.34,
and hydrochloric acid. Homogenized samples were
centrifuged at 1,000  g for 10 min, and supernatant
was collected and ultracentrifuged at 100,000  g for
1 h. The resulting cytosolic fraction supernatant was
kept for mitogen-activated protein kinase (MAPK)
study. The membrane fraction pellet was incubated in
TNE buffer containing 1% Triton-X100 for connexin-
43 analysis. The protein concentration was deter-
mined with Bradford assay (Bio-Rad Laboratories,
Inc., Hercules, California). All of the aforementioned
steps were conducted on ice at 4C to 5C.
Protein samples (20 mg) were separated by elec-
trophoresis on 8% sodium dodecyl sulfate poly-
acrylamide gels and transferred electrophoretically
onto polyvinylidene diﬂuoride membranes. These
membranes were blocked in a phosphate-buffered
saline (PBS) containing 0.05% (volume/volume)
Tween-20 and 5% (weight/volume) nonfat dry milk
and incubated overnight at 4C with primary anti-
bodies diluted in PBS containing 0.05% Tween-20 and
1% nonfat dry milk. After washing with PBS-Tween/
1% nonfat dry milk, membranes were hybridized
with horseradish peroxidase–conjugated secondary
antibody. Immunoreactive bands were detected
by electrochemiluminescence by using BioMax
MS/MR ﬁlms. Protein quantiﬁcation was performed
with Quantity One software (Bio-Rad). All expression
data are relative to glyceraldehyde-3-phosphate de-
hydrogenase staining for the same samples on thesame gels. The Online Appendix presents detailed
information about antibodies, including sources and
concentrations.
HISTOLOGY. Sections (5 mm) were cut at room tem-
perature and stained with Masson’s Trichrome.
Stained images were digitized and the ﬁbrosis area
was analyzed by using ImageJ 1.45s software. Fibrosis
was quantiﬁed by a blinded observer and expressed
as percent cross-sectional area, excluding blood ves-
sels and perivascular tissue.
CONFOCAL IMAGING. Cryosections (14 mm) were
ﬁxed with PBS containing 4% paraformaldehyde (pH
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20167.34), blocked, and permeabilized with PBS contain-
ing 2% normal donkey serum and 0.5% Triton X-100.
Primary antibodies (mouse anti-Cx43 [Chemicon];
rabbit anti-Cx40 [Zymed]) were diluted (1/200) in PBS
containing 2% normal donkey serum and 0.1% Triton
X-100 for overnight incubation with cryosections.
Alexa Fluor–conjugated donkey anti-rabbit (488 nm,
Invitrogen) or donkey anti-mouse (555 nm, Invi-
trogen) were used as secondary antibodies (1/600
dilution). Alexa Fluor–conjugated phalloidin (647 nm)
was used as an actin ﬁlament marker (1/600 dilution).
Slides were imaged in Z-series every 1 mm with an
Olympus FV-1000 confocal microscope (Olympus
America Inc., Center Valley, Pennsylvania). Aggregate
two-dimensional images of phalloidin and connexin-
43 ﬂuorescence were obtained from the 10 middle
layers of the Z-stack. Connexin-43 lateralization was
analyzed as described (12).
OPTICAL MAPPING. The heart was excised and the
coronary artery was perfused with Krebs solutionA B
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KH2PO4, 25 mM NaHCO3, 5.5 mM glucose, 1.25 mM
CaCl2, and 95% O2/5% CO2) at 10 ml/min and 37C.
After 30 min for stabilization and electrical/mechan-
ical decoupling with blebbistatin (15 mM), the heart
was loaded with di-4-ANEPPS (Biotium, Inc., Hay-
ward, California). A charge-coupled device (Car-
dioCCD, RedShirtImaging, LLC, Decatur, Georgia) was
used to record RA free wall ﬂuorescence at 2 kHz.
Bipolar electrodes were used to pace the superior
right atrium. Optical maps were obtained during 1.5 
threshold current 2-ms stimulation. Data were
analyzed with custom-written algorithms (details of
the methods are given in the Online Appendix).
STATISTICAL ANALYSIS. Data are expressed as mean
 SEM except for AF duration, which is expressed as
median and interquartile range (25% to 75%). The
Fisher exact test was applied to compare AF induc-
ibility. Multiple group comparisons were obtained
with an analysis of variance model. Bonferroni-E
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way rat and (B) an OSA rat, respectively. (C) AF duration.
ham. AF duration compared by using 1-way analysis of variance;
ram; OSA ¼ obstructive sleep apnea; SR ¼ sinus rhythm.
TABLE 1 Electrophysiological Variables
SCL SNRT WBCL aERP AVN-ERP
Sham (n ¼ 7) 193.3  9.7 211.4  5.8 97.9  2.4 34.0  1.0 82.9  3.2
Open (n ¼ 8) 181.6  9.4 204.5  12.4 103.8  5.7 37.0  1.2 84.9  4.5
OSA (n ¼11) 180.5  3.2 205.3  2.9 98.2  1.4 35.7  0.6 83.8  1.3
Values are mean  SEM and in ms. Comparisons were by 1-way analysis of variance.
aERP ¼ atrial effective refractory period; AVN-ERP ¼ atrioventricular node effective refractory period; OSA ¼
obstructive sleep apnea; SCL ¼ sinus node cycle length; SNRT ¼ sinus node recovery time; WBCL ¼ Wenckebach
cycle length.
TABLE 2 Echocardiographic Data
Sham Open OSA
Baseline (n ¼ 6)
LAD, mm 5.26  0.08 4.83  0.25 4.79  0.25
RAD, mm 4.81  0.16 4.54  0.23 4.21  0.13
LVAWd, mm 1.79  0.05 1.79  0.05 1.84  0.05
LVPWd, mm 1.85  0.07 1.74  0.08 1.85  0.07
LVDd, mm 8.25  0.09 7.94  0.15 8.08  0.19
LVDs, mm 4.38  0.18 4.05  0.16 4.30  0.11
LVFS, % 47.0  1.8 49.0  1.6 46.6  2.0
LV mass, mg 1073  28 981  45 1057  26
RVAW, mm 0.56  0.06 0.55  0.03 0.67  0.06
RVD, mm 3.74  0.09 3.75  0.09 3.24  0.23
Lt PV (S), cm/s 51.4  3.5 47.3  2.0 52.4  2.2
Lt PV (D), cm/s 34.5  2.5 31.2  2.0 31.9  0.7
Lt PV (S/D) 0.68  0.05 0.73  0.04 0.84  0.05
4-week (n ¼ 6)
LAD, mm 5.33  0.10 5.36  0.10 5.63  0.17
RAD, mm 4.68  0.14 4.95  0.24 5.09  0.40
LVAWd, mm 1.91  0.03 1.94  0.04 2.00  0.09
LVPWd, mm 1.84  0.09 1.93  0.08 1.94  0.11
LVDd, mm 8.23  0.10 8.48  0.14 8.99  0.22*
LVDs, mm 4.32  0.11 4.08  0.17 4.86  0.21†
LVFS, % 47.5  1.1 51.9  1.6 46.1  1.3†
LV mass, mg 1107  30 1204  51 1346  115‡
RVAW, mm 0.61  0.06 0.70  0.05 0.88  0.09*
RVD, mm 3.76  0.15 3.80  0.26 3.69  0.25
Lt PV (S), cm/s 50.8  3.2 47.0  2.1 40.8  4.0
Lt PV (D), cm/s 30.7  2.6 30.2  1.5 30.4  0.7
Lt PV (S/D) 1.67  0.09 1.56  0.04 1.34  0.11*
Values are mean  SEM. *p <0.01 vs sham (4-week), by 1-way analysis of
variance/Bonferroni-adjusted Student t tests. †p < 0.05 vs sham (4-week).
‡p <0.05 vs open (4-week).
D ¼ diastolic; LAD ¼ left atrial diameter; Lt ¼ left; LV ¼ left ventricular;
LVAWd ¼ left ventricular anterior wall thickness; LVDd ¼ left ventricular dimen-
sion in diastole; LVDs ¼ left ventricular dimension in systole; LVFS ¼ left ven-
tricular fractional shortening; LVPWd ¼ left ventricular posterior wall thickness;
OSA ¼ obstructive sleep apnea; PV ¼ pulmonary venous ﬂow; RAD ¼ right atrial
diameter; RV ¼ right ventricular; RVAW ¼ right ventricular anterior wall thickness;
RVD ¼ right ventricular dimension; S ¼ systolic; S/D ¼ systolic/diastolic pulmonary
venous ﬂow ratio.
J A C C V O L . 6 4 , N O . 1 9 , 2 0 1 4 Iwasaki et al.
N O V E M B E R 1 1 , 2 0 1 4 : 2 0 1 3 – 2 3 Repetitive OSA Causes AF-Promoting Remodeling
2017corrected Student t tests were applied to evaluate
individual mean differences when the analysis of
variance revealed signiﬁcant group effects. All data
satisﬁed statistical criteria for normal distribution,
except for AF duration, which satisﬁed normal distri-
bution criteria after logarithmic transformation. Two-
tailed p values <0.05 were considered signiﬁcant.
RESULTS
ACUTE RESPONSES TO OSA. At baseline, esophageal
pressure recordings during ventilation were –8.8 
0.9 mm Hg, –10.2  0.8 mm Hg, and –9.2  0.9 mm Hg
for the sham, open airway, and OSA groups, respec-
tively (p ¼ NS). OSA produced acute increases in
negative intrathoracic pressure generation (Online
Figure 1). Ventilatory arrest with open airways pro-
duced much smaller pressure changes. Maximal
negative intrathoracic pressure averaged –44.7  2.4
mm Hg in OSA rats versus –16.2  0.4 mm Hg in
open airway rats (p < 0.001). Correspondingly, acute
OSA produced statistically signiﬁcant LA dilation
(Figure 2), which was not seen in other groups. Arte-
rial blood gases conﬁrmed signiﬁcant oxygen desa-
turation and hypoventilation in OSA rats (Online
Table 1). Open airway rats showed a mild decrease
in the partial pressure of oxygen, with no signiﬁcant
desaturation or hypercapnia. During acute OSA,
stroke volume decreased, likely because of deep
negative intrathoracic pressure. Heart rate also
decreased, causing further reductions in cardiac
output (Online Figure 2).
AF SUSCEPTIBILITY CHANGES WITH REPEATED OSA.
Figure 3 shows changes in the AF substrate with
repeated OSA over 4 weeks. Burst pacing often failed
to induce AF in open airway rats (Figure 3A), while
commonly inducing AF in OSA rats (Figure 3B). Mean
AF duration increased w20-fold in chronic OSA rats
compared with sham rats (Figure 3C). AF inducibility
in the absence of acute OSA was also substantially
increased in chronic OSA rats (Figure 3D). We tested
AF inducibility in the presence of superimposed acute
OSA in rats not inducible at baseline; the goal was to
mimic the effect of acute OSA episodes occurring in
the presence of cardiac remodeling due to chronic
repetitive OSA. Superimposed acute OSA further
increased the inducibility of AF, with 5 (62.5%) of 8
previously noninducible chronic OSA rats becoming
inducible, versus 5 (38%) of 13 open airway rats and 2
(18%) of 11 sham rats. The result was AF inducibility
in a total of 82.4% of chronic OSA rats (Figure 3E).
CARDIAC REMODELING PRODUCED BY CHRONIC
REPETITIVE OSA. Repetitive OSA clearly produced a
substrate for AF susceptibility. Thus, the potentialunderlying cardiac remodeling changes were exam-
ined. There were no signiﬁcant differences in elec-
trophysiological parameters, including atrial ERP,
among the 3 groups (Table 1). Similarly, electrocar-
diogram parameters did not change between baseline
and 4 weeks (Online Table 2). Blood pressure values
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2018at end of study did not differ among groups (Online
Table 3). However, echocardiography revealed sig-
niﬁcant LV remodeling in chronic OSA rats (Table 2).
Statistically signiﬁcant increases in LV diameter and
LV mass occurred, indicating eccentric hypertrophy.
Right ventricular (RV) anterior wall thickness also
increased, and the pulmonary venous systolic/
diastolic ﬂow ratio decreased, indicating LV diastolic
dysfunction. LV systolic function (as indicated by LV
fractional shortening) did not change. The heart
weight/body weight ratio was signiﬁcantly increased
in chronic OSA rats (sham 2.69  0.05 mg/g; open 2.63
 0.06 mg/g; OSA 2.91  0.05 mg/g; p < 0.005 vs openOpen OSA
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¼ obstructive sleep apnea.and sham). There were no long-term effects of re-
petitive OSA on cardiac output (Online Figure 3).
Because atrial refractoriness did not change, we
wondered whether chronic OSA might be causing
conduction changes predisposing to reentry. Optical
mapping was therefore performed to precisely assess
conduction. Figure 4A shows activation maps from
each group. These were subjected to detailed quanti-
tative conduction velocity analysis (Online Appendix),
which revealed highly signiﬁcant conduction slowing
in chronic OSA rats (Figure 4B).
CONNEXIN CHANGES AND FIBROSIS. To understand
the mechanisms underlying the conduction slowing
caused by repetitive OSA, we analyzed changes in
connexin expression and ﬁbrous tissue content. Mild,
but statistically signiﬁcant, ﬁbrosis occurred in OSA
rats (Online Figure 4). Because the extent of ﬁbrosis
seemed insufﬁcient to explain the conduction
changes in OSA rats, other possibilities were analyzed,
including altered Naþ-channel subunit expression and
connexin changes. Although Naþ-channel alpha
subunit gene expression was unaffected by OSA
(Online Figure 5), connexin-43 showed substantial
remodeling. Figure 5A presents images of immuno-
ﬂuorescence staining of connexin-43 from LA tissue,
which was reduced in OSA rats. Quantitative analysis
is presented in Figure 5B and indicates a statistically
signiﬁcant reduction of w58% in OSA rats. Further-
more, there was substantial connexin redistribution
to lateral cell margins in OSA rats (Figure 5C). Neither
connexin-40 nor phosphoconnexin-43 antibodies
provided resolvable immunoﬂuorescence signals.
We pursued the analysis of connexin expression
by using Western blots. Figure 6A shows bands cor-
responding to total and ser368-phosphorylated con-
nexin-43, with quantitative analyses presented in
Figure 6B. Total connexin-43 expression in chronic
OSA rats was less than in sham rats, and qualitatively
similar to the immunoﬂuorescence data in Figure 5B.
Phosphorylated connexin expression was quantita-
tively smaller in both open airway and OSA rats, with
wide variation and no statistically signiﬁcant differ-
ences among groups. Consistent with previous
observations of extremely weak connexin-40
expression in rat atria (12), connexin-40 was not
detectable (Online Figure 6). Finally, we examined
potential mechanisms underlying connexin changes.
Previous evidence pointed to p38-MAPK regulation of
connexin expression (13). Figure 6A shows Western
blots for total and phosphorylated p38-MAPK, with
corresponding quantitative data presented in
Figure 6C. The p38-MAPK phosphorylation ratios
were signiﬁcantly increased in both the open airway
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2019and OSA rats. No changes in ERK expression or
phosphorylation were noted (Online Figure 7).
DISCUSSION
The present study represents the ﬁrst experimental
analysis of the effects of long-term repetitive OSA on
the cardiac substrate for AF, to our knowledge. We
found substantial increases in AF vulnerability,
including increased duration and inducibility of AF.
Underlying remodeling included atrial conduction
slowing, with no changes in atrial refractoriness.
Conduction slowing was accompanied by important
changes in atrial connexin-43 expression and distri-
bution, along with modest, but statistically signiﬁ-
cant, increases in atrial ﬁbrous tissue content. In
addition, cardiac structure/function remodeling was
seen in terms of LV dilation, hypertrophy, and dia-
stolic dysfunction, along with RV hypertrophy.
COMPARISON WITH PREVIOUS ANIMAL STUDIES
AND CONSIDERATIONS OF THE MODEL. A variety
of animal studies have explored the atrial arrhyth-
mogenic properties of acute OSA (5,9,14,15). Auto-
nomic nervous system activation, particularly of the
vagal component, plays an important role. However,
acute LA dilation/stretch caused by increased venous
return due to negative intrathoracic pressures also
contributes (9). Severe hypercapnia alters atrial
electrophysiology, both lengthening atrial ERP and
prolonging conduction time, whereas hypoxia has
limited effects (16).
The present study is, to the best of our knowledge,
the ﬁrst animal investigation to examine the effects
of chronic repetitive OSA, as typically occurs in pa-
tients, on the substrate for AF. Our rats were exposed
to 20 cycles of obstructive apnea per day, achieving
negative intrathoracic pressures of about –50 mm Hg,
which is similar to the clinically observed levels of
about –65 mm Hg achieved in patients (17). We found
that chronic repetitive OSA produces a vulnerable
substrate for AF, with both ventricular function
changes (predominantly diastolic dysfunction) and
prominent conduction disturbances. Taken together
with our previous study of acute OSA (9), our results
point to complex AF pathophysiology in OSA syn-
drome (Central Illustration). Acute OSA promotes AF
inducibility via autonomic changes and acute LA
stretch. However, in our previous study, acute OSA
alone did not increase AF duration and produced AF
inducibility in only a minority of lean rats. By adding
diastolic dysfunction that enhanced LA dilation un-
der OSA conditions, obesity substantially increased
AF inducibility with acute OSA. The cardiac remod-
eling resulting from repetitive OSA in the presentstudy clearly had an AF-promoting effect, even in the
absence of acute OSA, with prolonged AF duration
and increased AF inducibility (Figures 3C and 3D).
When exposed to acute OSA, chronic OSA rats dis-
played further increased AF inducibility (Figure 3E).
Thus, the atrial remodeling and cardiac function dis-
turbances caused by repetitive OSA episodes are
themselves arrhythmogenic but also sensitize the
heart to the immediate AF-promoting effects of acute
OSA (Central Illustration).
RELATIONSHIP TO CLINICAL OBSERVATIONS AND
POTENTIAL IMPORTANCE. The AF-promoting effects
of OSA in humans are well established (18). The
presence and severity of OSA predict AF recurrences
in patients taking antiarrhythmic drugs (19,20) and
after AF ablation (21). Furthermore, OSA treatment
with continuous positive airway pressure reduces
recurrence rates after AF ablation (22).
Recent studies have demonstrated signiﬁcant car-
diac remodeling in patients with OSA. OSA augments
atrial electromechanical delay and P-wave dispersion,
which increase with OSA severity (23). Patients
with OSA exhibit prolonged atrial conduction times,
longer P waves, slowed atrial conduction velocities,
lower atrial electrogram voltages, and more complex
electrograms (11,24). Signal-averaged P-wave dura-
tion is increased by OSA and signiﬁcantly decreases
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2020with continuous positive airway pressure treatment
(25). OSA is also associated with LV hypertrophy and
dilation, as well as an increased risk of systolic
dysfunction (26).
Our ﬁndings are consistent with and shed light on
clinical observations. In clinical databases, it is difﬁ-
cult to determine whether OSA directly causes cardiac
remodeling or whether the observed associations
are due to related conditions such as obesity. We
found that repeated OSA episodes are sufﬁcient to
induce signiﬁcant atrial conduction abnormalities, to
enhance AF susceptibility, and to produce LV and RV
hypertrophy, LV dilation, and diastolic dysfunction.
Furthermore, our results provide insights into the
mechanisms underlying AF-promoting conductiondisturbances, including extensive connexin remod-
eling and increased atrial ﬁbrous tissue content. In
addition to providing insights into mechanisms, our
results have relevance to therapeutic approaches.
Atrial ﬁbrosis reverses slowly, if at all (27); therefore,
to prevent the development of irreversible compo-
nents of the substrate, it may be important to treat
OSA as promptly as possible. In addition, gene
transfer approaches have demonstrated the feasi-
bility of restoring connexins in paradigms involving
AF related to impaired connexin expression (28,29).
These observations highlight the possibility of
mechanism-targeted therapy of AF associated with
conduction disorders, if the underlying basis can be
identiﬁed.
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CENTRAL ILLUSTRATION Mechanisms by Which OSA Leads to AF
(Top) Acute obstructive sleep apnea (OSA) episodes promote atrial ﬁbrillation (AF) via left atrial (LA) dilation and stretch (second box).
However, for AF to be manifest, an underlying substrate is needed. Chronic repetitive OSA episodes lead to an AF substrate by the mechanisms
shown in the third box. Repeated OSA produces cardiac remodeling, including left ventricular (LV) dilation and hypertrophy. LV hypertrophy
causes diastolic dysfunction. Diastolic dysfunction leads to LA dilation, stretch, and ﬁbrosis. LA stretch causes phosphorylation of the mitogen-
activated protein kinase p-38, which promotes ﬁbrosis. In addition, LA connexin-43 expression is altered, with both reduced levels and
displacement of the connexins from the cell ends (where they mediate cell-to-cell coupling) to the lateral cell margins. LA ﬁbrosis and LA
connexin changes, in combination with LA dilation and stretch, produce an AF substrate. (Bottom) Illustration of how OSA causes AF. Individual
acute episodes raise AF risk (blue lines), but in the absence of an underlying AF-prone substrate, they are not enough to reach the threshold
(dashed black line) necessary to cause AF occurrence. Over longer periods (months to years), repeated OSA episodes induce cardiac remodeling
that produces a substrate for AF (red line); therefore, the AF risk increase caused by individual OSA episodes reaches the threshold and causes
clinical AF. Acute OSA episodes can then readily trigger AF episodes in the presence of the substrate caused by cardiac remodeling that was
triggered by previous repeated OSA episodes.
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2021MECHANISTIC INSIGHTS. We identiﬁed a number of
aspects of cardiac remodeling caused by repetitive
OSA that likely contribute to the enhanced AF sus-
ceptibility that we noted. Atrial ﬁbrosis is a known
proﬁbrillatory substrate (30). However, although the
ﬁbrosis we observed in the present model was sta-
tistically signiﬁcant, it remained relatively modest:
w70% increase compared with the 16-fold increase
underlying the AF substrate in a canine congestive
heart failure model (31). The precise relationship
between ﬁbrosis extent and AF promotion is unclear;
therefore, despite its relatively modest nature,
ﬁbrosis might have contributed to the AF seen with
repeated OSA. However, there is extensive evidence
for important contributions of connexin remodeling
to the AF substrate (32), suggesting that the connexin
changes we observed played a signiﬁcant role. Assuch, the present ﬁndings provide a new, clinically
relevant paradigm for the contribution of connexin
changes to AF. In addition to electrophysiological
remodeling, the contribution of altered cardiac
hemodynamic function to OSA-associated AF should
not be overlooked. The LV dysfunction we noted
likely participated, particularly by enhancing the LA
stretch during acute OSA, as we reported previously
with LV hypertrophy and diastolic dysfunction
resulting from obesity (9).
STUDY LIMITATIONS. The biological factors connect-
ing repetitive OSA to atrial remodeling must still be
determined. OSA causes acute LA stretch, and
repeated stretch is a major contributor to atrial
remodeling associated with AF (33). Stretch causes
p38-MAPK phosphorylation, which activates ﬁbro-
blasts and promotes ﬁbrosis (34). We observed
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: In a
rat model, repetitive episodes of sleep apnea are
associated with left ventricular diastolic dysfunction
and dilation, atrial ﬁbrosis, and disruption of the atrial
connexin proteins. These factors could contribute to
the development of atrial ﬁbrillation.
TRANSLATIONAL OUTLOOK: The development of
treatments that prevent or reverse substrate changes
in the atria by inhibiting atrial ﬁbrosis, improving
intercellular electrical communication, or restoring
normal atrial connexin expression and distribution
may reduce the incidence of atrial ﬁbrillation in
patients with sleep apnea.
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2022increased p38 phosphorylation with OSA, which might
have contributed to its ﬁbrogenic properties. The
mechanisms that might underlie connexin-43 changes
with OSA and the effects of MAPKs are somewhat un-
clear. Some studies show that p38 and ERK MAPK
activation enhance connexin expression (13,35),
whereas others suggest that p38 MAPK activation im-
pairs connexin-43 phosphorylation and gap junction
conductance (36). Myocardial stretch may also have
complex effects, with in vitro stretch enhancing con-
nexin-43 expression but in vivo stretch reducing it (37).
Hypoxia itself slowly and reversibly down-regulates
connexin-43 expression (38). Inﬂammatory pathways
could also be involved. There is also evidence for roles
of hypercapnia in both acute AF-promoting effects of
OSA (16) and sympathetic activation (39), which could
have contributed to long-term remodeling. Clearly,
morework is needed to understand themolecular basis
of cardiac remodeling caused by repetitive OSA. The
model developed here may be valuable for the sys-
tematic mechanistic analyses needed.
Like all animal models of human disease, the
model we developed here is not a perfect counterpart
of any human condition. It does provide insights into
the cardiac remodeling caused by repetitive obstruc-
tive apnea, and shows that this remodeling produces
a substrate that can maintain AF. Clinical investiga-
tion is needed to validate the applicability of our
ﬁndings to humans. Further work in this and other
animal models will also be necessary to go further in
establishing the basic mechanisms coupling sleep
apnea to proarrhythmic cardiac remodeling.
CONCLUSIONS
We successfully developed an animal model of AF
promotion due to repetitive OSA, which displaysmany of the clinical features seen in patents with
OSA-related AF. The AF-associated substrate includes
atrial conduction slowing due to connexin remodel-
ing and atrial ﬁbrosis, along with OSA-induced ven-
tricular function changes. This work provides insights
into mechanisms underlying an important clinical
problem, as well as a novel model that can be used for
further mechanistic exploration.
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